XML 82 R22.htm IDEA: XBRL DOCUMENT
v3.24.2.u1

Net Loss per Share | 6 Months Ended
--- | ---
Jun. 30, 2024
Earnings Per Share [Abstract] |
Net Loss per Share | NET INCOME (LOSS) PER SHARE Basic and diluted net income (loss) per share was calculated as follow:
| Three Months Ended June 30, |  | Six Months Ended June 30, |  |
(in thousands, except share and per share data) | 2024 |  | 2023 |  | 2024 |  | 2023 |  |  |  |
Numerator: |  |  |  |  |  |  |  |  |  |  |
Net income (loss) | $ | 90,833 |  |  | $ | (55,712) |  |  | $ | 39,067 |  |  | $ | (79,732) |  |  |  |  |
Denominator: |  |  |  |  |  |  |  |  |  |  |
Weighted average shares of common stock outstanding—basic | 200,440,473 |  |  | 168,737,764 |  |  | 200,216,035 |  |  | 157,415,524 |  |  |  |  |
Net income (loss) per share— basic | $ | 0.45 |  |  | $ | (0.33) |  |  | $ | 0.20 |  |  | $ | (0.51) |  |  |  |  |
Effective of dilutive securities |  |  |  |  |  |  |  |  |  |  |
Time-based restricted stock units | 244,804 |  |  | — |  |  | 163,072 |  |  | — |  |  |  |  |
Employee stock purchase plan | 116,034 |  |  | — |  |  | 76,776 |  |  | — |  |  |  |  |
Dilutive potential common shares | 360,838 |  |  | — |  |  | 239,848 |  |  | — |  |  |  |  |
Weighted average shares of common stock outstanding—diluted | 200,801,311 |  |  | 168,737,764 |  |  | 200,455,883 |  |  | 157,415,524 |  |  |  |  |
Net income (loss) per share— diluted | $ | 0.45 |  |  | $ | (0.33) |  |  | $ | 0.19 |  |  | $ | (0.51) |  |  |  |  |
Basic and diluted weighted average shares of common stock outstanding for the three and six months ended June 30, 2024 and June 30, 2023 include the weighted average effect of outstanding pre-funded warrants for the purchase of shares of common stock for which the remaining unfunded exercise price is $0.01 or less per share. The Company’s potentially dilutive securities include outstanding stock options, unvested restricted stock units and warrants to purchase shares of common stock for the three and six months ended June 30, 2024 and 2023. For the three and six month periods ended June 30, 2023, during which the Company recorded a net loss, all potentially dilutive securities have been excluded from the computation of diluted net loss per share as the effect would be to reduce the net loss per share, and thus they are considered “anti-dilutive.” For these periods, the weighted average number of shares of common stock outstanding used to calculate both basic and diluted net loss per share of common stock is the same. For the three and six month ended June 30, 2024, the Company reported net income. For these periods, the dilutive effect of outstanding stock options, restricted stock units and warrants were calculated using the treasury stock method, whereby all such awards were assumed to be exercised at the beginning of the period. The hypothetical proceeds from such exercises, including the average unrecognized stock compensation expense for outstanding stock options and restricted stock units, were assumed to be used to purchase outstanding common stock at the average price during the period. The net share impact of dilutive securities was added to the weighted average basic common shares outstanding to calculate weighted average diluted shares outstanding. The Company excluded the following potential shares of common stock, presented based on amounts outstanding at each period end, from the computation of diluted net income (loss) per share for the periods indicated because including them would have had an anti-dilutive effect:
| Three Months Ended June 30, |  | Six Months Ended June 30, |  |
| 2024 |  | 2023 |  | 2024 |  | 2023 |  |  |  |
Options to purchase shares of common stock | 9,906,298 |  |  | 3,583,186 |  |  | 9,906,298 |  |  | 3,583,186 |  |  |  |  |
Unvested restricted stock units | 7,800,805 |  |  | 5,859,232 |  |  | 7,800,805 |  |  | 5,859,232 |  |  |  |  |
Warrants to purchase shares of common stock (excluding prefunded warrants, which are included in basic shares outstanding) | 76,378,805 |  |  | 80,246,459 |  |  | 76,378,805 |  |  | 80,246,459 |  |  |  |  |
| 94,085,908 |  |  | 89,688,877 |  |  | 94,085,908 |  |  | 89,688,877 |  |  |  |  |

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//260/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-3 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration